Vicore Pharma Holding AB (publ) reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was SEK 288.41 million compared to SEK 296.48 million a year ago. Basic loss per share from continuing operations was SEK 3.99 compared to SEK 4.25 a year ago.